Synthesis, solution conformation and anti-HIV activity of novel 3′-substituted-2′,3′-dideoxy-5-hydroxymethyl-uridines and their 4,5-substituted analogues

Antiviral Chemistry and Chemotherapy

Volumn 14, Issue 3, 2003, Pages 127-138

  Poznanski, Jaroslaw ^a   Bretner, Maria ^a   Kulikowski, Tadeusz ^a   Balzarini, Jan ^b   Van Aerschot, Arthur ^b   De Clercq, Erik ^b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXY 3' FLUORO 5 HYDROXYMETHYLURIDINE; 2',3' DIDEOXY 3' FLUOROURIDINE; 3' AZIDO 2',3' DIDEOXY 5 HYDROXYMETHYLURIDINE; 3' AZIDO 2',3' DIDEOXYURIDINE; 3' FLUOROTHYMIDINE; AMMONIA; FLUORINE DERIVATIVE; FORMALDEHYDE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG CONFORMATION; DRUG OXIDATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME BINDING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0041736500     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020301400302     Document Type: Article

References (43)

1. Ajmera S, Babat AR, Danenberg K & Danenberg PV (1984) Synthesis and biological activity of 5-fluoro-2′,3′-dideoxy-3′ -fluorouridine and its 5′-phosphate. Journal of Medicinal Chemistry 27:11-14.
2. Altona C, Ippel JH, Westra Hoekzma AJA, Erkelens C, Groesbeek M & Donders LA (1989) Relationship between proton-proton NMR coupling constants and substituent eleectronegatives. V. empirical substitutent constants deduced from ethanes and propanes. Magnetic Resonance in Chemistry 27:564-576.
3. Balzarini J, Baba M, Pauwels R, Herdewijn P & De Clercq E (1988) Anti-retrovirus activity of 3′-fluoro- and 3′-azido-substituted pyrimidine 2′,3′-dideoxynudeoside analogues. Biochemical Pharmacology 37:2847-2856.
4. Balzarini J, De Clercq E, Mertes MP, Shugar D & Torrence PF (1982) 5-Substituted 2′-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthase. Biochemical Pharmacology 31:3673-3682.
5. Balzarini J, Van Aerschot A, Pauwels R, Baba M, Schols D, Herdewijn P & De Clercq E (1989) 5-halogeno-3′-fluoro-2′,3′ -dideoxyuridines as inhibitors of human immunodeficiency irus (HIV): potent and selective anti-HIV activity of 3′-fluoro-2′,3′ -dideoxy-5-chlorouridine. Molecular Pharmacology 35:571-577.
6. Barchi JJ Jr, Jeong LS, Siddiqui MA & Marquez VE (1997) Conformational analysis of the complete series of 2′ and 3′ monofluorinated dideoxyuridines. Journal of Biological & Biophysical Methods 34:11-29.
7. Bazin H, Chattopadhaya J, Datema R, Ericson AC, Johansson NGBaker BR, Schwan TJ & Santi DV (1966) Nonclassical antimetabolites. XXV. Inhibitors of thymidine kinase. I. A new spectrophotometric assay. Inhibition by nucleoside derivatives. Journal of Medicinal Chemistry 9:66-72.
8. Bazin H, Chattopadhaya J, Datema R, Ericson AC, Johansson NG, Hensen J, Koshida R, Karin M, Öberg B, Remand G, Stening G, Vrang L, Wahren B & Wu JC (1989) An analysis of the inhibition of replication of HIV and multv by some 3′-blocked pyrimidine analogues. Biochemical Pharmacology 38:109-119.
9. Bergstrom DE, Swarding DJ, Wisor A & Hoffman MR (1991) Evaluation of thymidine, dideoxythymidine and fluorine substituted deoxyribonucleoside geometry by the Mindo/3 technique: the effect of fluorine substitution on nucleoside geometry and biological activity. Nucleosides Nucleotides 10:693-697.
10. Cadet J, Taieb C, Remin M, Niemczura WP, Hruska FE. (1980) Conformational studies of alpha- and beta-pyrimidine 2′ -deoxyri-bonucleosides in the syn and anti conformation. Biochimica et Biophysica Acta 608:435-445.
11. Cheng YC, Dutschman GE, Bastow KF, Sarngadharan MG & Ting RYC (1987) Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. Journal of Biological Chemistry 262:2187-2189.
12. Clark M, Cramer III RD & Van Opdenbosch N (1989) Validation of the general purpose Tripos 5.2 force field. Journal of Computational Chemistry 10:982-1012.
13. Cline RE, Fink RM & Fink K (1959) Synthesis of 5-substituted pyrimidines via formaldehyde addition. Journal of the American Chemical Society 81:2521-2527.
14. Cobas C, Cruces J & Sardina FJ (2000) MestRe-C 2.3a, Magnetic Resonance Companion NMR Data Processing Program. Santiago de Compostela, Spain: Department of Organic Chemistry, Faculty of Chemistry, University of Santiago de Compostela.
15. Creton EM, Xie M-Y, Bevan RJ, Goudgaon NM & Schinazi RF (1991) Catabolism of 3′-azido-3′-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3′-amino-3′ -deoxythymidine, a highly toxic catabolite for human bone marrow cells. Molecular Pharmacology 39:258-266.
16. De Leeuw HPM, Haasnoot CAG & Altona C (1980) Empirical correlations between conformational parameters in β-D-faranoside fragments derived from a statistical survey of crystal structures of nucleic acid constituents. Israel Journal of Chemistry 20:108-126.
17. Everaert DH, Peeters OM, De Ranter CJ, Blaton NM, Van Aerschot A & Herdewijn P (1993) Conformational analysis of substituent effects on the sugar puckering mode and the anti-HIV activity of 2′,3′-dideoxypyrimidine nucleosides. Antiviral Chemistry & Chemotherapy 4:289-299.
18. Felczak K, Bremer M, Kulikowski T & Shugar D (1993) High yield regioselective thiation of biologically important pyrimidinones, dihydropyrimidinones and their ribo, 2′-deoxyribo and 2′,3′ -dideoxyribonucleosides. Nucleosides Nucleotides 12:245-261.
19. Gelmon K, Montaner SG, Fanning M, Smith IRM, Falutz J, Tsoukaas C, Gill J, Wells G, O'Shaughness M, Wainberg M & Ruedy J (1989) Nature, time course and dose dependence of zidovudine- related side effects. Results from the Multicentre Canadian Azidothymidine Trial. AIDS 3:555-561.
20. Gill PS, Rarick M, Brynes RF, Cauey D, Loureiro C & Levine AM (1987) Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 107:502-505.
21. Gunther H (1980) NMR Spectroscopy, John Wiley and Sons, Chichester.
22. Guschlbauer W & Jankowski K (1980) Nucleoside conformation is determined by the electronegativity of the sugar substituent. Nucleic Acids Research 8:1421-1433.
23. Haasnoot CAG, De Leeuw FAAM & Altona C (1980) The relationship between proton-proton NMR coupling constants and substituent electronegatives. Tetrahedron 36:2783.
24. Hansch C, Leo A, Unger SH, Kim KH, Nikaitani D & Lien EC (1973) 'Aromatic' substituent constants for structure-activity correlations. Journal of Medicinal Chemistry 16:1207-1216.
25. Herdewijn P, Balzarini J, De Clercq E, Pauwels R, Baba M, Broder S & Vanderhaege H (1987) 3′-substituted 2′,3′-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) Agents. Journal of Medicinal Chemistry 30:1270-1278.
26. Hicks N, Howarth OW & Hutchinson DW (1991) NMR studies of the flexibility of the Glycosyl ring in thymidine and uridine nucleosides. Carbohydrate Research 216:1-9.
27. Itahara T & Koga S (1991) Oxidation of thymidine by peroxomono and peroxodisulfate ions. Chemical Letters 1991:85-88.
28. Kong X-B, Zhu Q-Y, Vidal PM, Watanabe KA, Polsky B, Armstrong D, Ostrander M, Lang AS Jr, Muchmore E & Chou T-C (1922) Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-Y-3′-deoxythymidine. Antimicrobial Agents Chemotherapy 36:808-818.
29. Larder BA, Darby G & Richman DD (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
30. Lin TS & Mancini WR (1983) Synthesis and antineoplastic activity of 3′-azido and 3′-amino analogues of pyrimidine deoxyribonucleoside. Journal of Medicinal Chemistry 26:544-548.
31. Plavec J, Thibaudeau C & Chattophadhayaya J (1996) How do energetics of the stereoelectronic gauche and anomeric effects modulate the conformation of nucleos(t)ides? Pure and Applied Chemistry 68:2137-2145.
32. Plavec J, Tong W & Chattophadhayaya J (1993) How do the gauche and anomeric effects drive the pseudorotational equilibrium of the pentofaranose moiety of nucleosides? Journal of American Chemical Society 115:9734-9746.
33. 1H NMR conformational study of antiherpetic C5-substituted 2′-deoxyuridines: insight into the nature of structure-activity relationships. Biochemical & Biophysical Research Communications 272:64-74.
34. Raleigh JA & Blackburn BJ (1978) Substrate conformation in 5′AMP-utilizing enzymes: 8,5-cycloadenosine-5′-monophosphate. Biochemical & Biophysical Research Communications 83:1061-1066.
35. Remin M & Shugar D (1972) Conformation of the 5′-exocyclic group in nucleosides and nucleotides in aqueous solution from specific assignments of the HS′ and HS″ signals in the NMR spectra. Biochemical & Biophysical Research Communications 48:636-642.
36. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Milduan D, Hirsch MS, Jackson GG, Durack DT & Nusinoff-Lehrman S (1987) The AZT Collaborative Working Group. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. New England Journal of Medicinal Chemistry 317:192-197.
37. Taylor EW, Van Roey P, Schinazi RF & Chu CK (1990) A stereo-chemical rationale for the activity of anti-HIV nucleosides. Antiviral Chemistry & Chemotherapy 1:163-173.
38. Van Aerschot A, Herdewijn P, Balzarini J, Pauwels R & De Clercq E (1989) 3′-fluoro-2′,3′-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2′- and 3′- fluorinated 2′,3′-dideoxynucleoside analogues. Journal of Medicinal Chemistry 32:1743-1749.
39. Van Roey P & Schinazi RF (1990) The crystal and molecular structure of 3′-fluoro-3′-deoxythymidine, a potent anti-HIV nucleoside. Antiviral Chemistry & Chemotherapy 1:93-98.
40. Van Roey P, Salerno JM, Chu CK & Schinazi RF (1989) Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus. Proceedings of National Academy of Sciences USA 86:3929-3933.
41. Vandamme AM, Van Vaerenbergh K & De Clercq E (1998) Anti-human immunodeficiency virus drug combination strategies. Antiviral Chemistry & Chemotherapy 9:187-203.
42. Walker RE, Parjer RI, Kovass JA, Masur H, Lane HC, Carleton S, Kiirkk LE, Gralnick HR & Fauci AS (1988) Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi's Sarcoma treated with zidovudine. Annals of Internal Medicine. 108:372-376.
43. Wiberg KB, Murcko MA, Laidig KE & McDougall PJ (1990) Origin of the 'Gauche Effect' in substituted ethanes and ethenes.